SYNDESI THERAPEUTICS
Actief
0686.599.355 - 1348 Ottignies-Louvain-la-Neuve
People administring SYNDESI THERAPEUTICS
| Name | Role / Mandate | Year |
|---|---|---|
| Christina Takke | Bestuurder | 2021, 2020, 2019 |
| Emmanuel Lacroix | Bestuurder | 2021, 2020, 2019 |
| Fiona MacLaughlin | Bestuurder | 2021 |
| Jean Combalbert | Bestuurder | 2021, 2020, 2019 |
| Jeanne Bolger | Bestuurder | 2021, 2020 |
| Jonathan Savidge | Gedelegeerd bestuurder | 2021, 2020, 2019 |
| King Aidan | Bestuurder | 2021, 2020, 2019 |
| Morton Graugaard Døssing | Bestuurder | 2021, 2020, 2019 |
| Roy Twyman | Bestuurder | 2021, 2020, 2019 |
| Veerle Catry | Vertegenwoordiger | 2021, 2020, 2019 |
Companies administring SYNDESI THERAPEUTICS
| Name | Enterprise # | Role | Year |
|---|---|---|---|
| BDO auditeurs | 0431.088.289 | Commissaris | 2021, 2020, 2019 |
Companies that are administered by SYNDESI THERAPEUTICS
| Name | Enterprise # | Role | Year |
|---|---|---|---|
| No data available |
Companies holding participations in SYNDESI THERAPEUTICS
| Participations in | Value | Amount | % Direct | % Indirect | Type |
|---|---|---|---|---|---|
| UCB BIOPHARMA | UCB BIOPHARMA | 0543.573.053 | Shareholder | ||
| Société Régionale d'Investissement de Wallonie | Société Régionale d'Investissement de Wallonie | 0219.919.487 | Shareholder | ||
| VIVES II - Louvain Technology Fund | VIVES II - Louvain Technology Fund | 0838.819.178 | Shareholder | ||
| V-Bio Fund 1 | V-Bio Fund 1 | 0642.766.540 | Shareholder |
SYNDESI THERAPEUTICS has participations in
| Participations in | Value | Amount | % Direct | % Indirect | Type |
|---|---|---|---|
| No data available |